ASP Health Inc., a private medical device company focused on improving cancer survival rates, has received the “Top Pathology Solutions Provider 2025” award from MedTech Outlook magazine for its revolutionary point-of-care pathology platforms.
The company has developed a suite of three innovative platforms, ASP Prep™, ASP View™, and ASP Assist™, which are designed to bring speed, precision, and standardization to cancer diagnostics at the point of care.
“Our platforms drive a wave of transformation in diagnostic processes, enabling precise, real-time evaluations,” said Dr. Hari Subramanian, ASP Health’s chief operating officer.
ASP Health is working to democratize advanced cancer diagnostics by making cutting-edge tools accessible to all healthcare facilities, including smaller community hospitals that traditionally lack specialized pathology resources.
“Our specialty is a complete end-to-end solution for preparing and viewing cell slides, enhanced by software that quickly identifies target cells to expedite the diagnostic decision-making process,” explained John Hart, ASP Health’s president and CEO.
The company initially focused on addressing limitations in Rapid On-Site Evaluation (ROSE), a critical cancer diagnostic procedure. By automating what was previously a manual, specialized process, ASP Health has made ROSE scalable and accessible to more healthcare facilities.
Dr. Gautam Balakrishnan, an interventional pulmonologist at Mosaic Life Care in St. Joseph, Missouri, praised the technology’s impact on community hospitals.
“ASP Health helped us solve a common problem faced by many community hospitals, which is the inability to perform ROSE. The ROSE Prep™ system allows us to automatically prepare high-quality specimen slides and transmit real-time feedback with telepathology.”
The company’s ROSE View™ microscope is fully robotic and can be operated remotely via the internet, allowing cytopathologists to assess samples from virtually anywhere. The system integrates artificial intelligence to assist with diagnostic decisions and reduce the time required for diagnosis.
“AI-powered assistance acts as an extra set of eyes, ensuring no critical details are missed and significantly reducing the time required for diagnosis,” Dr. Subramanian explained.
